Inotrope versus placebo therapy in cardiogenic shock: Rationale and study design of the CAPITAL DOREMI2 trial

Simon Parlow, Pietro Di Santo, Lee H. Sterling, Laura Goodliffe, Pouya Motazedian, Graeme Prosperi-Porta, Baylie Morgan, Zandra Koopman, Richard G. Jung, Melissa Fay Lepage-Ratte, Lisa Robinson, Hannah Feagan, Trevor Simard, George A. Wells, Kwadwo Kyeremanteng, Craig Ainsworth, Faizan Amin, Jeffrey A. Marbach, Shannon M. Fernando, Marino LabinazEmilie P. Belley-Cote, Benjamin Hibbert, Rebecca Mathew

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Inotrope versus placebo therapy in cardiogenic shock: Rationale and study design of the CAPITAL DOREMI2 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences